Frequency Therapeutics Inc. shares fall up to 77% on NASDAQ
The National Association of Securities Dealers Automated Quotations (NASDAQ) Composite Index opened at 13,381.43 and closed at 13,227.70 on 23rd March 2021. The highest it touched was 13,405.14 and lowest 13,202.43
Today’s top 5 Bottom Performers:
Frequency Therapeutics Inc. (Change% -77.98 priced at $8.3)
Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.
Windtree Therapeutics Inc. (Change% -34.29 priced at $2.6)
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Jiayin Group Inc. ADR (Change% -29.92 priced at $10)
Jiayin Group, Inc. engages in online individual finance marketplace in China connecting individual investors and individual borrowers. The company was founded by Dinggui Yan and is headquartered in Shanghai, China.
Anixa Biosciences Inc. (Change% -29.31 priced at $4.8)
Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body’s immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body’s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient’s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Upstart Holdings Inc. (Change% -28.14 priced at $116.6)
BurgerFi International, Inc. operates as burger franchises, corporate-owned restaurants, renowned for delivering an exceptional, all-natural premium burger experience in contemporary and sustainably designed restaurants. It uses natural American angus beef with no steroids, antibiotics, growth hormones, chemicals or additive. The company was founded in February 2011 and is headquartered in Miami, FL.
